Skip to main content

Advertisement

Table 1. Characteristics of 25 patients (39 tumors) treated for hepatocellular carcinoma with radiotherapy

From: Optimal follow-up duration for evaluating objective response to radiotherapy in patients with hepatocellular carcinoma: a retrospective study

Characteristic Value
Age (years)a 60.7 (40.7 to 76.2)
Gender [cases (%)]  
  Men 18 (72)
  Women 7 (28)
ECOG performance status [cases (%)]  
  0 10 (40)
  1 11 (44)
  2 4 (16)
Underlying hepatitis [cases (%)]  
  B 20 (80)
  C 2 (8)
  Alcoholic 1 (4)
  No hepatitis 2 (8)
Child-Pugh classification [cases (%)]  
  A 19 (76)
  B 6 (24)
Tumor size (cm) a 1.7 (0.7 to 16.3)
GTV (cm3) a 6.84 (0.72 to 114.7)
T category [cases (%)]  
  1 1 (4)
  2 12 (48)
  3 12 (48)
Pre-radiotherapy AFP concentration (IU/mL) a 25.94 (1.42 to 34,132)
AFP concentration change a 0.9 (0.01 to 1,132.5)
Total radiotherapy dose (Gy) a 55.0 (40.0 to 60.0)
Daily radiotherapy dose (Gy) a 2.5 (2 to 4)
Biologically equivalent dose (Gy10) a 67.1 (56.0 to 78.0)
Previous TACE [number of tumors (%)]  
  Yes 23 (58.9)
  No 16 (41.1)
Interval between radiotherapy and TACE (months) a 3.2 (0.5 to 13.0)
  1. ECOG, Eastern Cooperative Oncology Group; GTV, gross tumor volume; AFP, α-fetoprotein; TACE, trans-arterial chemoembolization. aThese data are presented as median values with ranges in parentheses.